Bionano Genomics, Inc. (LON:0A4K)

Market Cap	10.11M +38.9%
Revenue (ttm)	22.74M +10.0%
Net Income	-24.24M
EPS	-2.54
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,768
Open	5.70
Previous Close	5.58
Day's Range	5.19 - 5.88
52-Week Range	5.00 - 80.86
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 10, 2026

About Bionano Genomics

Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It also provides Saphyr and Stratys systems, which are sample-to-result solutions for structural variation analysis by ...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2003
• Employees: 97
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0A4K

Financial Performance

In 2025, Bionano Genomics's revenue was $28.51 million, a decrease of -7.37% compared to the previous year's $30.78 million. Losses were -$26.40 million, -76.44% less than in 2024.

Financial numbers in USD

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 12, 2026

Data Sources Report a data error